New CureSearch Young Investigator Dr. Anthony Graves is studying molecular targets in N-Myc amplified neuroblastoma, a sub-type of the disease known to have poor outcomes. Dr. Graves studies the biology of a particular gene known to be involved in this high-risk sub-type.read more
Did You Know?
What We Fund
Among adults, less than 5% of those with cancer are enrolled in clinical trials. Yet for children, more than 60% of those with cancer participate in some form of clinical trial. CureSearch supports clinical trials that show promise in making a difference for children with cancer, today.